23 May 18

NEWS

Shore Capital acts as Joint Bookrunner on the placing by Dairy Crest Group Plc

    Shore Capital is delighted to have acted on the placing by Dairy Crest Group Plc to raise £70 million for the Company.   The placing represents approximately 9.98 per cent. of the Company’s issued share capital at a price of £4.95 pence per share. The placi

18 May 18

NEWS

Shore Capital Technology Conference - Session Highlights

On the morning of Tuesday, the 15th of May Shore Capital hosted its technology conference focussed on digital technology and how it is transforming industries at the Royal Institution, London. The conference brought together thought leaders from leading UK companies in the space, investors, and prof

03 May 18

NEWS

Shore Capital acts as Sole Bookrunner: Oversubscribed Placing to Raise £5.5m for Ixico Plc

IXICO plc ("IXICO" or the "Company")   IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, is pleased to announce that it is proposing to raise £5.5 million (before commissions and expenses) through a conditional placing of 19,642,856 Placing Shares at 28 pen

26 Apr 18

NEWS

Shore Capital appointed to provide Corporate Access and Research Services to Savannah Petroleum plc

Shore Capital is pleased to have been appointed to provide Corporate Access and Research Services to Savannah Petroleum (AIM: SVAP). Savannah Petroleum is a UK oil and gas company focused around the exploration, appraisal and development of the R1/R2 and R3/R4 PSC areas of the Agadem Rift Basin in

19 Apr 18

NEWS

Big pharma model is being challenged

Shore Capital Healthcare Analyst, Tara Raveendran, discusses how innovation, coming from small and mid-cap companies, is challenging big pharma on CNBC. Big pharma model is challenged, analyst says from CNBC.

17 Apr 18

NEWS

Life Science Analysis: What does Roche's takeover of Flatiron Health mean?

With Roche being particularly active on the real-world-data front with its recent acquisition of the US cancer data analytics firm Flatiron Health Inc, Healthcare Analyst Tara Raveendran discusses the broader implications of this transaction. Tara Raveedran’s article was published in the Apri

12 Apr 18

NEWS

Shore Capital Appointed Joint Broker to Sirius Minerals Plc

    Shore Capital is pleased to have been appointed as joint broker to Sirius Minerals Plc (Premium: SXX). Sirius Minerals is focused on the development of the Woodsmith Mine, which will access the world's largest and highest grade polyhalite deposit located in North Yorkshire, United

29 Mar 18

NEWS

Shore Capital’s Kevin MacDonald wins the Mudlark Award for Exceptional Performance in the Back Office

We’re delighted to announce that Kevin MacDonald, Head of Operations at Shore Capital, has won the Mudlark Award for ‘Exceptional Performance in the Back Office’ at the City of London Wealth Management Awards 2018. During the last 12 years at Shore Capital, Kevin’s contribut

26 Mar 18

NEWS

Preliminary Results for the Year Ended 31 December 2017

Strong Group performance with significant growth in revenues and profitability Shore Capital, the independent investment group specialising in capital markets, asset management and principal finance, today announces its preliminary results for the year ended 31 December 2017.   Financial hig

14 Mar 18

NEWS

Shore Capital acts as Sole Bookrunner: Successful Completion of Placing to Raise £12m for Yu Group

   Yü Group PLC (the "Group" or “Company”)   Successful completion of placing to raise £12.0 million  Yü Group PLC (AIM: YU.), the independent supplier of gas and electricity to the UK corporate sector, is delighted to announce that the Company

01 Mar 18

NEWS

Shore Capital Healthcare Conference - Session Highlights

On the morning of Wednesday, the 28th of February Shore Capital hosted its inaugural healthcare conference focussed on Orphan and Rare Diseases at the Royal Institution, London. The conference brought together thought leaders from leading UK companies in the space, investors, and healthcare professi

01 Mar 18

NEWS

Shore Capital appointed Nominated Adviser and Sole Broker to Produce Investments Plc

  Produce Investments Plc - Change of Broker Produce Investments plc (AIM: PIL), a leading operator in the fresh potato and daffodil sectors, announces the appointment of Shore Capital as its Nominated Adviser and Sole Broker with immediate effect.   For further information contact: P

1 2